Summary
UnitedHealth Group (UNH) reported strong revenue growth of 6% for the second quarter of 2024, reaching $98.9 billion, driven by robust performance in its OptumRx and Optum Health segments, as well as continued growth in UnitedHealthcare's domestic offerings. Despite the overall revenue increase, net earnings attributable to common shareholders declined by 23% to $4.2 billion, or $4.54 per diluted share. This decline was primarily due to a significant $1.2 billion loss recognized on the sale of South American operations and a substantial $8.3 billion loss related to the sale of its Brazil operations earlier in the year, alongside impacts from the Change Healthcare cyberattack. The company highlighted continued expansion in its UnitedHealthcare business, serving 1.6 million more people domestically, particularly in commercial offerings and Medicare Advantage. However, the Change Healthcare cyberattack led to direct response costs of $776 million and business disruption impacts of $334 million for the quarter, contributing to increased medical costs and a higher medical care ratio of 85.1%. Looking ahead, UNH is navigating pressures from Medicare Advantage rate reductions and evolving risk adjustment models, while also managing ongoing Medicaid redeterminations.
Financial Highlights
55 data points| Revenue | $98.86B |
| Cost of Revenue | $11.34B |
| Gross Profit | $87.52B |
| SG&A Expenses | $13.16B |
| Operating Expenses | $90.98B |
| Operating Income | $7.88B |
| Interest Expense | $985.00M |
| Net Income | $4.22B |
| EPS (Basic) | $4.58 |
| EPS (Diluted) | $4.54 |
| Shares Outstanding (Basic) | 921.00M |
| Shares Outstanding (Diluted) | 928.00M |
Key Highlights
- 1Total revenues increased by 6% to $98.9 billion for the quarter ended June 30, 2024, compared to the prior year, driven by growth in Optum and UnitedHealthcare segments.
- 2Net earnings attributable to UnitedHealth Group common shareholders decreased by 23% to $4.2 billion ($4.54 per diluted share) for the quarter, impacted by losses on divestitures and the Change Healthcare cyberattack.
- 3UnitedHealthcare saw a 5% revenue increase and served 1.6 million more people domestically, primarily in commercial and Medicare Advantage offerings, though overall UnitedHealthcare medical membership declined 5% due to divestitures.
- 4Optum revenues grew 12% driven by Optum Health and Optum Rx, despite a 3% revenue decline and a significant drop in earnings from operations for Optum Insight due to the Change Healthcare cyberattack.
- 5The company incurred $776 million in direct response costs and $334 million in business disruption impacts from the Change Healthcare cyberattack during the quarter.
- 6Significant losses were recognized from the sale of Brazil operations ($7.1 billion) and ongoing South American operations held for sale ($1.2 billion) during the first half of 2024.
- 7The company repurchased 6 million shares for approximately $3.1 billion and increased its quarterly dividend by 11.7% to an annual rate of $8.40 per share.